{"description":"Documents matching '\"0910-AJ14\"'","count":2,"total_pages":1,"results":[{"title":"Regulatory Agenda","type":"Notice","abstract":"The Regulatory Flexibility Act of 1980 and Executive Order 12866 require the issuance of an inventory of rulemaking actions under development throughout the Department, offering for public review summarized information about forthcoming regulatory actions.","document_number":"2026-16597","html_url":"https://www.federalregister.gov/documents/2026/08/14/2026-16597/regulatory-agenda","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-08-14/pdf/2026-16597.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-16597.pdf?1786625113","publication_date":"2026-08-14","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Office of the Secretary"}],"excerpts":"232 \n Pediatric Study Plan Requirements for New Drug and Biologics License Applications \n 0910-AI89 \n \n \n 233 \n Good Laboratory Practice for Nonclinical Laboratory Studies \n 0910-AJ01 \n \n \n 234 \n \n Transparency in Direct-to-Consumer Advertising \n (Reg Plan Seq No. 48) \n \n <span class=\"match\">0910-AJ14</span> \n \n \n References in boldface appear in The Regulatory Plan in part II of this issue of the \n Federal Register \n .\n \n \n \n Food and Drug Administration—Final Rule Stage \n \n Sequence No. \n Title \n \n Regulation\n Identifier No. \n \n \n \n 235 \n Medication Guide; Patient Medication"},{"title":"Introduction to the Unified Agenda of Federal Regulatory and Deregulatory Actions-2026","type":"Notice","abstract":"Publication of the 2026 Unified Agenda of Federal Regulatory and Deregulatory Actions represents a key component of the regulatory planning mechanism prescribed in Executive Order (\"E.O.\") 12866, \"Regulatory Planning and Review,\" (58 FR 51735, as amended) and reaffirmed in E.O. 13563, \"Improving Regulation and Regulatory Review,\" (76 FR 3821) and E.O. 14192, \"Unleashing Prosperity Through Deregulation.\" The Regulatory Flexibility Act requires that agencies publish semiannual regulatory agendas in the Federal Register describing regulatory actions they are developing that may have a significant economic impact on a substantial number of small entities (5 U.S.C. 602). The Unified Agenda of Federal Regulatory and Deregulatory Actions (Unified Agenda) helps agencies fulfill all of these requirements. All Federal regulatory agencies have chosen to publish their regulatory agendas as part of this publication. The complete publication of the 2026 Unified Agenda contains 78 Federal agency regulatory agendas available to the public at www.reginfo.gov. The 2026 Unified Agenda publication appearing in the Federal Register includes the agency Regulatory Flexibility Agendas, in accordance with the publication requirements of the Regulatory Flexibility Act. Agency Regulatory Flexibility Agendas contain only those Agenda entries for rules that are likely to have a significant economic impact on a substantial number of small entities and entries that have been selected for periodic review under section 610 of the Regulatory Flexibility Act.","document_number":"2026-16603","html_url":"https://www.federalregister.gov/documents/2026/08/14/2026-16603/introduction-to-the-unified-agenda-of-federal-regulatory-and-deregulatory-actions-2026","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-08-14/pdf/2026-16603.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-16603.pdf?1786625114","publication_date":"2026-08-14","agencies":[{"raw_name":"REGULATORY INFORMATION SERVICE CENTER","name":"Regulatory Information Service Center","id":449,"url":"https://www.federalregister.gov/agencies/regulatory-information-service-center","json_url":"https://www.federalregister.gov/api/v1/agencies/449","parent_id":null,"slug":"regulatory-information-service-center"}],"excerpts":"46 \n Modernizing Regulations to Promote Electronic Submission and Reduce Paper Submission \n 0910-AI50 \n Proposed Rule Stage. \n \n \n 47 \n Substances Generally Recognized as Safe \n 0910-AJ02 \n Proposed Rule Stage. \n \n \n 48 \n Transparency in Direct-to-Consumer Advertising \n <span class=\"match\">0910-AJ14</span> \n Proposed Rule Stage. \n \n \n 49 \n Proactive Disclosure of Complete Response Letters \n 0910-AJ16 \n Proposed Rule Stage. \n \n \n 50 \n Electronic Labeling for Medical Devices \n 0910-AJ17 \n Proposed Rule Stage. \n \n \n 51 \n Nutrient Content Claims for Added Sugars \n 0910-AJ20 \n"}]}